Clinical and etiological characteristics of enterovirus 71-related diseases during a recent 2-year period in Korea.
Human enterovirus 71 (EV 71) has caused large-scale outbreaks of hand-foot-and-mouth disease (HFMD), particularly in the Asian-Pacific region. In this study, we report a major outbreak of EV 71 infection in Korea and describe the clinical differences between EV 71 and non-EV 71 enterovirus infections. We prospectively enrolled patients with suspected viral infections during a recent 2-year period through a nationwide surveillance system. We identified 719 patients with suspected HFMD or herpangina using real-time PCR and genotyping based on VP1 sequence analysis. The major pathogen causing HFMD changed substantially from 2008 to 2009, with EV 71 becoming the most common cause of HFMD in Korea in 2009. We successfully identified the enteroviral genotypes for 218 of the 719 patients. Patients with EV 71 infections tended to be younger than those with non-EV 71 enteroviral infections and presented with HFMD and meningoencephalitis. In addition, the occurrence of fever, headache, and neck stiffness was significantly higher in patients with EV 71 infections. Multivariable analysis showed that for patients presenting with HFMD, fever, or a sore throat, each covariate was independently associated with EV 71 infection; the adjusted odds ratios (with 95% confidence intervals in parentheses) for these variables were 31.86 (10.04 to 101.09), 4.76 (1.71 to 13.25), and 0.18 (0.04 to 0.77), respectively. Our results indicate that EV 71 was a major cause of HFMD in Korea during the study period. In addition, we found that clinical symptoms may be helpful in the early identification of patients with EV 71 infections.
Ryu
Wi-Sun
WS
Division of Enteric and Hepatitis Viruses, National Institute of Health, Korea Center for Disease Control and Prevention, Seoul, Republic of Korea.
Kang
Byounghak
B
Hong
Jiyoung
J
Hwang
Seoyeon
S
Kim
Jonghyun
J
Cheon
Doo-Sung
DS
D000704:Analysis of Variance; D002648:Child; D002675:Child, Preschool; D003384:Coxsackievirus Infections / Q000175:diagnosis / Q000453:epidemiology / Q000821:virology; D029821:Enterovirus A, Human / Q000235:genetics*; D005260:Female; D005838:Genotype; D005843:Geography; D006232:Hand, Foot and Mouth Disease; D006557:Herpangina; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D008297:Male; D015995:Prevalence; D011446:Prospective Studies; D056910:Republic of Korea / Q000453:epidemiology; D020133:Reverse Transcriptase Polymerase Chain Reaction
J Med Virol. 2009 Feb;81(2):317-24
19107980
Pediatr Int. 2006 Jun;48(3):250-6
16732789
Clin Infect Dis. 1999 Jul;29(1):184-90
10433583
Neurology. 2003 May 27;60(10):1651-6
12771257
Pediatrics. 2002 Jun;109(6):e88
12042582
N Engl J Med. 1999 Sep 23;341(13):929-35
10498487
Virus Res. 2008 Nov;137(2):206-12
18706461
J Neurovirol. 2003 Feb;9(1):126-8
12587076
Pediatr Infect Dis J. 1999 Dec;18(12):1033-9; quiz 1040
10608620
N Engl J Med. 1999 Sep 23;341(13):936-42
10498488
FEMS Microbiol Rev. 2002 Mar;26(1):91-107
12007645
Arch Virol. 2003 Jul;148(7):1369-85
12827466
Microbiol Immunol. 2002;46(9):621-7
12437029
Virol J. 2009 Jul 07;6:95
19583870
J Med Virol. 2002 Jun;67(2):217-23
11992582
Clin Infect Dis. 2001 Jan 15;32(2):236-42
11170913
Clin Infect Dis. 2000 Sep;31(3):678-83
11017815
Clin Microbiol Infect. 2007 Jul;13(7):677-82
17441979
J Contam Hydrol. 2003 Mar;61(1-4):117-29
12598099
Clin Infect Dis. 2004 Jun 15;38(12):1784-8
15227628
Emerg Infect Dis. 2003 Mar;9(3):291-3
12643822
Emerg Infect Dis. 2009 Jan;15(1):79-82
19116058
J Clin Virol. 2009 Apr;44(4):262-7
19269888
Clin Infect Dis. 2007 Mar 1;44(5):646-56
17278054
J Clin Microbiol. 2009 Jul;47(7):2351-2
19439545
Emerg Infect Dis. 2007 Nov;13(11):1733-41
18217559
Lancet. 2000 Oct 14;356(9238):1338
11073035
Arch Virol. 2009;154(7):1139-42
19506798
J Clin Microbiol. 2006 Aug;44(8):2698-704
16891480
J Clin Microbiol. 2009 Nov;47(11):3653-62
19776232
J Clin Microbiol. 2001 Nov;39(11):4093-6
11682535
J Infect Dis. 2001 Mar 15;183(6):850-6
11237800